squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors#825504ClinicalTrials.gov
• Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma#872821ClinicalTrials.gov
• Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)#864360ClinicalTrials.gov
• A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer#369844ClinicalTrials.gov
• Metastatic promoting role of mesenchymal stem cells in oral squamous cell carcinoma revealed by an improved bone marrow chimeric model#379026OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma#811183ClinicalTrials.gov
• S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx#844059ClinicalTrials.gov
• Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC#854966ClinicalTrials.gov
• Preoperative Treatment With Cetuximab and/or IMC-A12#868750ClinicalTrials.gov
• Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy#826190ClinicalTrials.gov
• Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma#871891ClinicalTrials.gov
• Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer#895674ClinicalTrials.gov
• Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy#889412ClinicalTrials.gov
• Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.#854019ClinicalTrials.gov
• Single-cell transcriptomic analysis of cutaneous squamous cell carcinoma identifies an NR1H3-associated angiogenic macrophage state.#465186NCBI PubMed Central
• Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease#321701ClinicalTrials.gov
• Investigation of a Behavioral Substitute for Sunbathing#880192ClinicalTrials.gov
• Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer#67887ClinicalTrials.gov
• Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer#172282ClinicalTrials.gov
• A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.#230394ClinicalTrials.gov
• AK117 (Anti-CD47) + Anti-EGFR for R/M HNSCC#256867ClinicalTrials.gov
• DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation.#368070NCBI PubMed Central
• Ipilimumab for Head and Neck Cancer Patients#405167ClinicalTrials.gov
• Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC#848178ClinicalTrials.gov
• BIBW 2992 (Afatinib) in Head & Neck Cancer#876595ClinicalTrials.gov
• A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp#833800ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer#143633ClinicalTrials.gov
• SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma#148743ClinicalTrials.gov
• Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study#181749ClinicalTrials.gov
• Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer#889747ClinicalTrials.gov
• Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma#841499ClinicalTrials.gov
• The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers#866328ClinicalTrials.gov
• Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer#890206ClinicalTrials.gov
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer#343837ClinicalTrials.gov
• Sweet apple e-cigarette vapor differentially modulates the mTOR pathway in oral squamous cell carcinoma cell lines.#430876NCBI PubMed Central
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants#873417ClinicalTrials.gov
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors#806826ClinicalTrials.gov
• Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy#140999ClinicalTrials.gov
• BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study#208440ClinicalTrials.gov
• Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer#832236ClinicalTrials.gov
• Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer#865681ClinicalTrials.gov
• A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)#881526ClinicalTrials.gov
• MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7#129227PMC Full-Text (OAI)
• Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC#307464ClinicalTrials.gov
• 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC#321687ClinicalTrials.gov
• Sintilimab Plus NCT or NCRT Versus NCRT for ESCC#417547ClinicalTrials.gov
• Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC#448272ClinicalTrials.gov
• Comprehensive molecular characterization of cutaneous squamous cell carcinoma reveals determinants of metastatic progression#463583bioRxiv / medRxiv
• Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC#825565ClinicalTrials.gov
• Study of S-1 in Combination With Radiotherapy in Esophageal Cancer#873191ClinicalTrials.gov